radioimmunotherapy


radioimmunotherapy

 [ra″de-o-im-mu″no-ther´ah-pe] use of radionuclides to deliver monoclonal antibodies to targeted cancer cells.

radioimmunotherapy

Immunology The use of radio-labeled–monoclonal antibodies that recognize specific antigens, and therefore concentrate in a particular tissue to treat disease Toxicity Myelosuppression, nausea, infections, cardiopulmonary toxicity

radioimmunotherapy

(rā′dē-ō-ĭm″ū-nō-thĕr′ă-pē) The use of radioactively labeled monoclonal antibodies to treat malignancies, e.g., breast cancers, non-Hodgkin's lymphoma, and prostate cancer. The monoclonal antibodies selectively bind with antigens on the tumor cells and deliver a dose of cell-killing radiation directly to those cells.